Your browser doesn't support javascript.
loading
Bufalin reverses multidrug resistance by regulating stemness through the CD133/nuclear factor-κB/MDR1 pathway in colorectal cancer.
Zhan, Yueping; Qiu, Yanyan; Wang, Haijing; Wang, Ziyuan; Xu, Jian; Fan, Guohua; Xu, Jianhua; Li, Wei; Cao, Yijun; Le, Van-Minh; Ly, Hai-Trieu; Yuan, Zeting; Xu, Ke; Yin, Peihao.
Affiliation
  • Zhan Y; Central Laboratory, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Qiu Y; Interventional Cancer Institute of Chinese Integrative Medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Wang H; Interventional Cancer Institute of Chinese Integrative Medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Wang Z; Department of Pathology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Xu J; Central Laboratory, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Fan G; Interventional Cancer Institute of Chinese Integrative Medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Xu J; Interventional Cancer Institute of Chinese Integrative Medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Li W; Department of General Surgery, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Cao Y; Department of General Surgery, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Le VM; Research Center of Ginseng and Medicinal Materials (CGMM), National Institute of Medicinal Materials, Ho Chi Minh City, Vietnam.
  • Ly HT; Research Center of Ginseng and Medicinal Materials (CGMM), National Institute of Medicinal Materials, Ho Chi Minh City, Vietnam.
  • Yuan Z; Interventional Cancer Institute of Chinese Integrative Medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Xu K; Shanghai Putuo Central School of Clinical Medicine, Anhui Medical University, Hefei, China.
  • Yin P; Central Laboratory, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Cancer Sci ; 111(5): 1619-1630, 2020 May.
Article in En | MEDLINE | ID: mdl-32058643
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bufanolides / Colorectal Neoplasms / Drug Resistance, Neoplasm / Transcription Factor RelA / AC133 Antigen / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Sci Year: 2020 Document type: Article Affiliation country: China Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bufanolides / Colorectal Neoplasms / Drug Resistance, Neoplasm / Transcription Factor RelA / AC133 Antigen / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Sci Year: 2020 Document type: Article Affiliation country: China Country of publication: United kingdom